Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonist

2013155 citationsJournal Article

Authors

Good health and well-being

Published in: Atherosclerosis

Volume 230, Issue 2, pp. 373-380

Field-Weighted Citation Impact: 1.96